Gallotta, Valerio
 Distribuzione geografica
Continente #
NA - Nord America 4.013
EU - Europa 3.741
AS - Asia 3.148
SA - Sud America 828
AF - Africa 83
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.829
Nazione #
US - Stati Uniti d'America 3.907
SG - Singapore 1.465
DE - Germania 1.085
CN - Cina 833
BR - Brasile 692
SE - Svezia 689
IT - Italia 401
PL - Polonia 335
FR - Francia 277
VN - Vietnam 224
GB - Regno Unito 187
UA - Ucraina 187
IN - India 184
IE - Irlanda 177
ID - Indonesia 114
FI - Finlandia 110
RU - Federazione Russa 93
HK - Hong Kong 48
AR - Argentina 46
TR - Turchia 44
CA - Canada 43
JP - Giappone 40
MX - Messico 38
BE - Belgio 34
IQ - Iraq 34
ES - Italia 31
NL - Olanda 30
BD - Bangladesh 28
EC - Ecuador 26
ZA - Sudafrica 26
AT - Austria 16
IR - Iran 16
KR - Corea 16
RO - Romania 16
PK - Pakistan 15
VE - Venezuela 14
CL - Cile 12
CZ - Repubblica Ceca 12
KE - Kenya 12
CH - Svizzera 11
CI - Costa d'Avorio 11
CO - Colombia 11
PY - Paraguay 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
GR - Grecia 9
JO - Giordania 9
MA - Marocco 9
AU - Australia 8
EG - Egitto 8
IL - Israele 8
KZ - Kazakistan 8
LT - Lituania 7
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
DK - Danimarca 5
HU - Ungheria 5
PA - Panama 5
PE - Perù 5
UY - Uruguay 5
BH - Bahrain 4
JM - Giamaica 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
MY - Malesia 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
BZ - Belize 2
DM - Dominica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GF - Guiana Francese 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
EE - Estonia 1
Totale 11.815
Città #
Chandler 847
Singapore 666
Ashburn 371
Warsaw 310
Beijing 184
Dublin 172
New York 134
San Mateo 131
Ann Arbor 117
Jacksonville 115
Jakarta 103
Los Angeles 102
Boston 89
Wilmington 88
Nanjing 85
Ho Chi Minh City 83
Nürnberg 71
Dearborn 69
Houston 69
Frankfurt am Main 65
Marseille 65
São Paulo 62
Hefei 61
Princeton 61
Hyderabad 60
Hanoi 56
Cattolica 54
Moscow 52
Rome 52
Helsinki 47
Redwood City 45
Munich 44
Woodbridge 44
Dallas 41
Fairfield 40
Milan 39
Hong Kong 37
Fuzhou 36
Brussels 34
The Dalles 33
Lawrence 32
Seattle 31
Buffalo 29
Tokyo 29
Nanchang 28
Chicago 25
Kunming 25
Rio de Janeiro 22
Augusta 21
Hangzhou 21
Boardman 20
Mountain View 20
Turku 20
Changsha 19
London 19
Norwalk 19
Belo Horizonte 18
Leawood 18
Shenyang 18
Tianjin 18
Düsseldorf 17
Bremen 16
Hebei 16
Johannesburg 16
Seoul 16
Atlanta 15
Lancaster 15
Roubaix 15
Shanghai 15
Amsterdam 14
Baghdad 14
Poplar 14
San Francisco 14
Santa Clara 14
Brooklyn 13
Dhaka 13
Izmir 13
Kent 13
Orem 13
Toronto 13
Denver 12
Jiaxing 12
Mexico City 12
Mumbai 12
Nuremberg 12
Salvador 12
Abidjan 11
Cambridge 11
Detroit 11
Vienna 11
Zhengzhou 11
Brasília 10
Curitiba 10
Falkenstein 10
Lappeenranta 10
Lauterbourg 10
Montreal 10
Nairobi 10
San Jose 10
Stockholm 10
Totale 5.792
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 835
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 347
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 272
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 269
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 200
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 197
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 193
Urologic surgery in gynecologic oncology: a large single-institution experience 173
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 168
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 167
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 164
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 163
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 159
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 156
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 153
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 151
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 147
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 132
Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series 131
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 131
Airway Closure during Surgical Pneumoperitoneum in Obese Patients 131
Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients. 129
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 126
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 125
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 122
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 122
From palliation to cure: PIPAC for peritoneal malignancies 122
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 118
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 116
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 116
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 114
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 113
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 113
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 113
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 113
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 112
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 112
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 110
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 110
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 107
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 106
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 105
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 105
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 104
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 103
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 101
Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study 101
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 101
Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study 101
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 100
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 99
A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial 99
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience 98
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 98
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 98
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 97
The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience 97
Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach 97
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 95
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 95
Technological innovation and personalized surgical treatment for early-stage endometrial cancer patients: A prospective multicenter Italian experience to evaluate the novel percutaneous approach 95
Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? 95
Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study 95
Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis 94
Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience 94
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 93
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 93
Krukenberg tumors: Seed, route and soil 93
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 90
Minimally invasive versus open pelvic exenteration in gynecological malignancies: A propensity-matched survival analysis 88
Secondary cytoreduction in ovarian cancer: who really benefits? 88
Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion 86
Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up 85
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 84
Prognostic factors for survival in patients with lung metastases from gynaecological tract cancers 82
Can the Modified Frailty Index (mFI) Predict Intraoperative and Postoperative Complications in Older Women with Endometrial Cancer Undergoing Laparoscopic or Robotic Surgery? A Multicenter Observational Study 81
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 81
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 81
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer 80
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 80
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 80
Minimally invasive secondary cytoreductive surgery for hepato-renal recess isolated recurrence of serous endometrial cancer in BRCA1 mutated patient 80
Role of robotic surgery in ovarian malignancy 79
Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection 78
Enhanced recovery after surgery (ERAS) in gynecology oncology 77
Robotic Secondary Cytoreduction with 3D Reconstruction for Isolated Recurrent Ovarian Cancer: A Stepwise Approach to Splenectomy 75
Total laparoendoscopic single-site surgery (LESS) hysterectomy in low-risk early endometrial cancer: a pilot study 75
ASO Author Reflections: Minimally Invasive Adjuvant Surgery in Locally Advanced Cervical Cancer: Which Role? 75
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 74
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 73
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs 72
Lung-protective ventilation during Trendelenburg pneumoperitoneum surgery: A randomized clinical trial 71
Radical Surgery in Advanced Cervical Cancer Patients Receiving Bevacizumab-Containing Chemotherapy: A "Real Life Experience" 71
Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study 71
Laparoscopy vs. Laparotomy for advanced ovarian cancer: A systematic review of the literature 71
Robotic Single-Port Platform in General, Urologic, and Gynecologic Surgeries: A Systematic Review of the Literature and Meta-analysis 69
Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery 68
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer 64
STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs 64
ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery-What We Know and Future Perspectives 63
Totale 11.860
Categoria #
all - tutte 50.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021415 0 0 0 0 0 26 59 25 65 62 146 32
2021/20221.057 88 43 15 135 38 20 23 137 40 81 201 236
2022/20232.107 337 301 175 322 120 265 97 134 246 20 51 39
2023/2024882 28 279 16 88 24 115 56 40 12 27 99 98
2024/20251.928 44 45 132 66 144 86 80 75 282 228 403 343
2025/20263.108 801 191 312 656 959 189 0 0 0 0 0 0
Totale 12.503